Orphan Diseases Drug Pipeline Database 2021 – ResearchAndMarkets.com
January 12, 2022DUBLIN–(BUSINESS WIRE)–The “Orphan Diseases Pipeline Database – 2021” report has been added to ResearchAndMarkets.com’s offering.
Orphan Diseases Pipeline Highlights Database 2021, provides the most up-to-date information on key pipeline products in the global Orphan Diseases Drug market.
It covers emerging therapies for Orphan Diseases in active clinical development stages including early and late-stage clinical trials. The pipeline data is presented in an excel dashboard with filtering options.
The pipeline data presented in this database helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
By Indication:
The database presents pipeline by Orphan Diseases indications.
By Clinical Trial Stages:
The database provides Orphan Diseases pipeline products by clinical trial stages including both early and late-stage development – phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
By Drug Mechanism Classes:
The database provides Orphan Diseases pipeline products by their dominant drug mechanism class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.
By Company:
The database provides Orphan Diseases pipeline products by the company.
SUMMARY:
- Orphan Diseases Pipeline by Indication
- Orphan Diseases Pipeline by Clinical Trial Phase
- Orphan Diseases Pipeline by Drug Mechanism Classes
- Orphan Diseases Pipeline by Company
For more information about this report visit https://www.researchandmarkets.com/r/s0mij3.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900